Pfizer pre–tax profit shoots up 70% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Pfizer pre–tax profit shoots up 70%

Mar 13, 2000

Pfizer has reported excellent results for the first quarter ended February 2000. Income from operations has jumped 12% bucking the trend in the pharmaceutical industry, which has been growing at 7–8%. The company has delivered topline growth despite Becousules being brought under price control, which implies that now almost 45% of the revenue of Pfizer the company accrues from price control. In India six brands viz. Becousules, Lorex, Protinex, Dolonex, Terramycin and Minipress XL account for 80% of the company’s sales.

(Rs m) 1QFY1999 1QFY2000 Change
Sales 707.3 790.3 11.7%
Other Income 15.0 19.0 26.7%
Expenditure 639.3 683.2 6.9%
Operating Profit (EBDIT) 83.0 126.1 51.9%
Operating Profit Margin (%) 12% 16%  
Interest 0.2 1.0 400.0%
Depreciation 17.6 12.7 -27.8%
Profit before Tax 65.6 112.4 71.3%
Extraordinary item      
Tax 24.6 46.5 89.0%
Profit after Tax/(Loss) 41.0 65.9 60.7%
Net profit margin (%) 5.8% 8.3%  

On the expenditure side, the company has made an extra provision of Rs 7 million, which is on account of amortisation of the compensation paid under Voluntary Retirement Scheme (VRS). The operating profit margins has increased from around 12% to 16% and pretax profits have grown 70%.

The sweetener is the 1:1 bonus declared by the company, which seems to be intended to assuage the minority shareholders who have been upset ever since the company got a permission for setting up a 100% subsidiary.

Equitymaster requests your view! Post a comment on "Pfizer pre–tax profit shoots up 70%". Click here!


More Views on News

PFIZER 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PFIZER for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Nov 26, 2021 (Close)